In the same study, the authors showed that MDA-MB-231 breast carcinoma cells were capable of activating breast MAIT cells in a TCR-ve, MR1-ve, and microbe-dependent manner, resulting in a strong IL-17 bias [28]. Here, IL17A is linked to breast carcinoma.